Gene therapy for neurological disorders: progress and prospects

被引:0
|
作者
Benjamin E. Deverman
Bernard M. Ravina
Krystof S. Bankiewicz
Steven M. Paul
Dinah W. Y. Sah
机构
[1] California Institute of Technology,Division of Biology and Biological Engineering
[2] Voyager Therapeutics,Department of Neurological Surgery
[3] University of California–San Francisco,undefined
[4] Present address: Stanley Center for Psychiatric Research at Broad Institute,undefined
[5] Cambridge,undefined
[6] MA,undefined
[7] USA.,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The potential of adeno-associated viral (AAV)-mediated gene therapy for neurological disorders is rapidly emerging. Evidence of clinical efficacy and safety, as well as durable transgene expression, has now been reported in several central nervous system disorders. Here, Sah and colleagues discuss key considerations in the design and development of therapeutic AAV vectors, highlighting promising therapeutic targets and recent clinical trials.
引用
收藏
页码:641 / 659
页数:18
相关论文
共 50 条
  • [1] Gene therapy for neurological disorders: progress and prospects
    Deverman, Benjamin E.
    Ravina, Bernard M.
    Bankiewicz, Krystof S.
    Paul, Steven M.
    Sah, Dinah W. Y.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (09) : 641 - 659
  • [2] Erratum: Gene therapy for neurological disorders: progress and prospects
    Benjamin E. Deverman
    Bernard M. Ravina
    Krystof S. Bankiewicz
    Steven M. Paul
    Dinah W. Y. Sah
    [J]. Nature Reviews Drug Discovery, 2018, 17 : 767 - 767
  • [3] Gene therapy for neurological disorders: progress and prospects (vol 17, pg 641, 2018)
    Deverman, Benjamin E.
    Ravina, Bernard M.
    Bankiewicz, Krystof S.
    Paul, Steven M.
    Sah, Dinah W. Y.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (10) : 768 - 768
  • [4] Correction: Progress in gene therapy for neurological disorders
    Michele Simonato
    Jean Bennett
    Nicholas M. Boulis
    Maria G. Castro
    David J. Fink
    William F. Goins
    Steven J. Gray
    Pedro R. Lowenstein
    Luk H. Vandenberghe
    Thomas J. Wilson
    John H. Wolfe
    Joseph C. Glorioso
    [J]. Nature Reviews Neurology, 2013, 9 (6) : 298 - 298
  • [5] Gene therapy progress and prospects: gene therapy of lysosomal storage disorders
    S H Cheng
    A E Smith
    [J]. Gene Therapy, 2003, 10 : 1275 - 1281
  • [6] Gene therapy progress and prospects: gene therapy of lysosomal storage disorders
    Cheng, SH
    Smith, AE
    [J]. GENE THERAPY, 2003, 10 (16) : 1275 - 1281
  • [7] Monogenic neurological disorders: Progress and prospects
    Mandel, JL
    [J]. M S-MEDECINE SCIENCES, 1996, 12 : 100 - 108
  • [8] Intrabody applications in neurological disorders: Progress and future prospects
    Miller, TW
    Messer, A
    [J]. MOLECULAR THERAPY, 2005, 12 (03) : 394 - 401
  • [9] Gene therapy for neurological disorders
    Choong, Chi-Jing
    Baba, Kousuke
    Mochizuki, Hideki
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (02) : 143 - 159
  • [10] Gene therapy Progress and Prospects: Gene therapy for the hemophilias
    Christopher E Walsh
    [J]. Gene Therapy, 2003, 10 : 999 - 1003